Aged; Aged, 80 and over; Alleles; Blotting, Northern; Female; Gene Expression/genetics; Genomic Imprinting; HT29 Cells; Humans; Insulin-Like Growth Factor Binding Protein 1/genetics; Insulin-Like Growth Factor Binding Protein 2/genetics; Insulin-Like Growth Factor Binding Protein 3/genetics; Insulin-Like Growth Factor Binding Protein 4/genetics; Insulin-Like Growth Factor Binding Protein 5/genetics; Insulin-Like Growth Factor Binding Protein 6/genetics; Insulin-Like Growth Factor II/genetics; Male; Mesothelioma/chemistry/metabolism; Placenta/chemistry/metabolism; Pleural Neoplasms/chemistry/metabolism; Polymerase Chain Reaction; Promoter Regions, Genetic/genetics; RNA, Messenger/analysis/genetics; RNA, Ribosomal, 18S/analysis/genetics; Radioimmunoassay; Receptor, IGF Type 1/analysis/genetics; Somatomedins/metabolism; Transcription, Genetic/genetics
Abstract :
[en] The expression of members of the IGF system in a mesothelioma from a patient suffering from hypoglycemia, in term placenta and HT29 colon adenocarcinoma cells were compared. Very high levels of IGF-II mRNA and protein were detected in the mesothelioma. Moreover, half of the IGF-II protein took the high-molecular-weight form. We also analyzed the parental imprinting status and the promoter usage of the IGF-II gene. Our results showed loss of imprinting (LOI) in the mesothelioma while the imprinting was maintained in HT29 cells, expressing moderate levels of the transcript. Promoter P4 was active in the three tissues we analyzed, whereas IGF-II mRNA transcription from promoter P3 was only detected in the mesothelioma and the placenta, expressing comparably high levels of the transcript. IGF-II gene structure was identical in the analyzed tissues and cells. The type-I receptor mRNA expression was very low in the tumor. IGFBP-2, -4 and -5 mRNAs were detected in the mesothelioma, while IGFBP-2, -3 and -5 transcripts were detected in the placenta. IGFBP-1 and -6 transcripts were not detected.
Research center :
ULg - Université de Liège
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Hodzic, D.
Delacroix, Laurence ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
Willemsen, P.
Bensbaho, K.
Collette, Julien ; Centre Hospitalier Universitaire de Liège - CHU > Chimie médicale
Broux, R.
Lefebvre, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Legros, Jean-Jacques ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique
Grooteclaes, M.
Winkler, Rose ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Language :
English
Title :
Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma.
Publication date :
1997
Journal title :
Hormone and Metabolic Research
ISSN :
0018-5043
eISSN :
1439-4286
Publisher :
Georg Thieme Verlag Stuttgart, Stuttgart, Germany
Volume :
29
Issue :
11
Pages :
549-55
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Humbel, R. E.: Insulin-like growth factors I and II. Eur J Biochem 190: 445-462 (1990)
Kornfeld, S.: The biogenesis of lysosomes. Annu Rev Cell Biol 5: 483-525 (1989)
Neilsen, F. C.: The molecular and cellular biology of insulin-like growth factor II. Progress in Growth Factor Research 4: 257-290 (1992)
Spagnoli, A., R. C. Rosenfeld: Insulin-like growth factor binding proteins. Curr Opin Endocrin Diab 4: 1-9 (1997)
Shimasaki, S., N. Ling: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1,-2, -3,-4,-5,and -6). Progress in Growth Factors Research 3: 243-266 (1991)
Werner, H., D. LeRoith: The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68: 183-223 (1996)
Reeve, A. E., M. R. Eecles, R. J. Wilkins, G. I. Bell, L. J. Millow: Expression of insulin-like growth factor II transcripts in Wilm's tumor. Nature 317: 258-260 (1985)
Minniti, C. P., L. J. Helman: IGF-II in the pathogenesis of rhabdomyosarcoma: a prototype of IGFs involvment in human tumorigenesis. In: Current Directions in Growth Factors Research. LeRoith D., M. K. Raizada. Plenum Press, New York (1994), pp327-345
Lambert, S., J. Vivario, J. Boniver, R. Gol-Winkler: Abnormal expression and structural modification of the insulin-like growth factor II gene in human colorectal tumors. Int J Cancer 46: 405-410 (1990)
Rogler, C. E., D. Yang, L. Rossetti, J. Donohoe, E. Alt, C. J. Chang, R. Rosenfeld, K. Neely, R. Hintz: Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor II transgenic mice. J Biol Chem 269: 13779-13784 (1994)
Christofori, G., P. Naik, D. Hanahan: A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigensis. Nature 369: 414-418 (1994)
Yonei, Y., M. Tanaka, Y. Azawa: Hypoglycemia: involvement of insulin-like growth factors. Liver 12: 90-93 (1992)
Ishida, S., M. Noda, N. Kuzuya, F. Kubo, S. Yamada, T. Yamanka, O. Isozaki, N. Hizuka, Y. Kanazawa: Big insulin-like growth factor II-producing hepatocellular carcinoma associated with hypoglycemia. Internal Medicine 34: 1201-1206 (1995)
Daughaday, W. H., M. A. Emanuele, M. H. Brooks, A. L. Barbara, M. Kapadia, P. Rotwein: Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 319: 1434-1440 (1988)
Sakamoto, T., H. Kaneshige, A. Takeshi, T. Tsushila, S. Hasegawa: Localized pleural mesothelioma with elevation of high molecular weight insulin-like growth factor II and hypoglycemia. Chest 106: 965-967 (1994)
Tycko, P.: Genomic imprinting: Mechanism and role in human pathology. Am J Pathol 144: 431-443 (1994)
Holthuizen, P., M. A. Van Dijk, R. J. Rodenburg, A. M. Koonen-Reemst, J. S. Sussenbach: Transnational regulation of the major promoters of the human IGF-II gene. Mol Reprod Dev 35: 391-393 (1993)
Kiefer, M. C., C. Schmid, M. Waldvogel, I., Schlaffer, E. Futo, F. R. Masiarz, K. Green, P. J. Barr, J. Zapf: Characterization of recombinant human insulin-like growth factor binding proteins 4, 5 and 6 produced in yeast. J Biol Chem 267: 12692-12699 (1992)
Ercolani, L., B. Florence, M. Denaro, M. Alexander: Isolation and complete sequence of a functional human Glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263: 15335-15341 (1988)
Bourguignon, J. P., A. Gérard, G. Deby-Dupont, R Franchimont: Effects of growth hormone therapy on the developmental changes of follicle stimulating hormone and insulin-like growth factor-I serum concentrations in Turner's syndrome. Clin Endocrincol 39: 85-89 (1993)
Fourney, R. M, J. Miyakosui, R. S. Day III, M. C. Patterson: Northern blotting: efficient RNA staining and transfer. Focus (Gibco/BRL) 10: 5-7 (1988)
Lambert, S., J. Collette, J. GiIHs, R Franchimont, C. Desaive, R. Gol-Winkler: Tumor IGF-II content in a patient with a colon adenocarcinoma correlates with abnormal expression of the gene. Int J Cancer 48: 826-830 (1991)
Besset, V., J. Collette, M. A. Chavin, P. Franchimont, M. Benahmed: Effect of transforming growth factor-β 1 on the insulin-like growth factor system in cultured porcine Leydig cells. Mol Cell Endocrinol 99: 251-257 (1994)
Lee, J. J., N. A. Costlow: A Molecular Titration assay to measure transcript prevalance levels. Methods Enzymol 152: 633-648 (1987)
Rainier, S., L. A. Johnson, C. J. Dobry, A. J. Ping, P. E. Grundy, A. P. Feinberg: Relaxation of imprinted genes in human cancer. Nature 362: 747-749 (1993)
Daughaday, W. H., B. Trivedi, M. Kapadia: Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. J Clin Endocrinol Metab 53: 289-294 (1981)
Zapf, J., H. Walter, E. R. Froesch: Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 68: 1321-1330 (1981)
Widmer, U., J. Zapf, E. R. Froesch: Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? J Clin Endocrinol Metab 55: 833-839 (1982)
Corden, R C. M. Hendricks, C. R. Kahn, K. Megyesi, J. Roth: Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. N Eng J Med 305: 1452-1455 (1981)
Shapiro, E. T., G. I. Bell, K. S. Polonsky, A. H. Rubenstein, M. C. Kew, H. S. Tager: Tumor hypoglycemia: Relationship to high molecular weight insulin-like growth factor-II. J Clin Invest 85: 1672-1679 (1990)
Jansen, M., F. M. A. van Schaik, J. L. Van den Brande, J. S. Sussenbach: Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett 179: 243-246 (1985)
Zumstein, P. P., C. Lüthi, R. Humbel: Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc Natl Acad Sci USA 82: 3169-3172 (1985)
Hudgins, W. R., B. Hampton, W. Burgess, J. F. Perdue: The identification of O-glycosylated precursors of insulin-like growth factor II. J Biol Chem 267: 8153-8160 (1992)
Lambert, S., A. Carlisi, J. Collette, P. Franchimont, R. Gol-Winkler: Insulin-like growth factor II in two human colon-carcinoma cell lines: gene structure and expression, and protein secretion. Int J Cancer 52: 404-408 (1992)
Leighton, P. A., R. S. Ingram, J. Eggenschwiler, A. Efstratiadis, S. M. Tilghman: Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375: 34-39 (1995)
Zhang, L., F. Kashanchi, Q. Zahn, S. Zahn, J. N. Brady, A. J. Fornace, P. Seth, L. Helman: Regulation of Insulin-like growth factor II promoter by p53: A potential mechanism for tumorigenesis. Cancer Res 56: 1367-1373 (1996)
Nichols, K. E, G. R. Gian, Y. X. Yan, A. J. Carvin, D. A. Haber: WT1 induces expression of insulin-like growth factor 2 in Wilm's tumor cells. Cancer Res 55: 4540-4543 (1995)
Camacho-Hubner, C., W. H. Busby, R. H. McCusker, G. Wright, D. R. Clemmons: Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem 267: 11949-11956 (1992)
Matsumoto, T., S. E. Gargosky, Y. Oh, R. G. Rosenfeld: Transcriptional and post-translational regulation of insulin-like growth factor-binding-protein-5 in rat articular chondrocytes. J Endocrinol 148: 355-369 (1996)
Spagnoli, A., R. G. Rosenfeld: The mechanism by which growth hormone brings about growth. Endocrinol Metab Clin North Am 25: 615-631 (1996)
Lee, T. C., Y. Zhang, C. Aston, R. Hintz, J. Jagirdar, M. A. Perle, M. Bun, W. N. Rom: Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res 53: 2858-2864 (1993)
Hernandez-Sanchez, C, H. Werner, C. T. Roberts Jr., E. J. Woo, T. W. Hum, S. M. Rosenthal, D. LeRoith: Differential regulation of insulin-like growth factor-I (IGF-I) receptor gene expression by ICF-I and basic fibroblastic growth factor. J Biol Chem 272: 4663-4670 (1997)
Rutten, A. A. J. J. L, E. Bermudez, W. Stewart, J. I. Everitt, C. L. Walker: Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II. Cancer Res 55: 3634-3639 (1995)